Screener
Ligand Pharmaceuticals LGND Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's free cash flow?
- Ligand Pharmaceuticals (LGND) reported free cash flow of $23.99M in Q2 2026.
- How has Ligand Pharmaceuticals's free cash flow changed year-over-year?
- Ligand Pharmaceuticals's free cash flow increased by 53.9% year-over-year, from $15.59M to $23.99M.
- What is the long-term trend for Ligand Pharmaceuticals's free cash flow?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's free cash flow has grown at a -8.6% compound annual growth rate (CAGR), from $70.04M to $48.91M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Ligand Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude